Literature DB >> 9499362

Cathepsin B expression and its correlation with tumor-associated laminin and tumor progression in gastric cancer.

A Khan1, M Krishna, S P Baker, R Malhothra, B F Banner.   

Abstract

OBJECTIVE: Cathepsin B, a lysosomal cysteine proteinase, is associated with degradation of laminin. Its activity has been shown to be increased in gastric carcinomas. Laminin is one of the major components of basement membrane involved in cell-matrix interactions and tumor progression. The objectives of this study were to correlate cathepsin B expression in tumor cells with tumor-associated laminin and to further correlate the two with tumor progression. DESIGN AND
SETTING: Resected gastric carcinomas (n = 29) taken from the surgical pathology files of the University of Massachusetts Medical Center, Worcester, were immunostained with cathepsin B and laminin using the avidin-biotin complex technique. Statistical analysis was performed using the exact linear by linear association test and exact Kruskal-Wallis test. Kaplan-Meier curves were plotted, and survival analysis was performed using a nonparametric log-rank test.
RESULTS: Cathepsin B was expressed in 27 (93%) of 29 tumors (11 weak and 16 strong). Staining of tumor-associated laminin showed patterns ranging from almost continuous (n = 4) to moderately discontinuous (n = 11) and highly fragmented (n = 14). The degree of cathepsin B staining in tumor cells significantly correlated with the laminin distribution pattern (P = .0001). The association between increased cathepsin B, decreased laminin, and higher tumor stage was also significant.
CONCLUSIONS: Increased cathepsin B expression by tumor cells associated with decreased tumor-associated laminin may suggest a mechanism for local tumor progression and metastasis. Staining for cathepsin B and laminin may be of prognostic value in gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499362

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

1.  Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.

Authors:  Izabela Podgorski; Bruce E Linebaugh; Mansoureh Sameni; Christopher Jedeszko; Sunita Bhagat; Michael L Cher; Bonnie F Sloane
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

2.  Imaging proteolysis by living human breast cancer cells.

Authors:  M Sameni; K Moin; B F Sloane
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

3.  A systems biology analysis of metastatic melanoma using in-depth three-dimensional protein profiling.

Authors:  Mee-Jung Han; Huan Wang; Lynn A Beer; Hsin-Yao Tang; Meenhard Herlyn; David W Speicher
Journal:  Proteomics       Date:  2010-11-17       Impact factor: 3.984

Review 4.  Cathepsin B: A sellsword of cancer progression.

Authors:  Olja Mijanović; Ana Branković; Alexander N Panin; Solomiia Savchuk; Peter Timashev; Ilya Ulasov; Maciej S Lesniak
Journal:  Cancer Lett       Date:  2019-02-20       Impact factor: 8.679

Review 5.  Cathepsins in digestive cancers.

Authors:  Siyuan Chen; Hui Dong; Shiming Yang; Hong Guo
Journal:  Oncotarget       Date:  2017-06-20

6.  CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma.

Authors:  Shi-Jie Wang; Dong Chao; Wei Wei; Gang Nan; Jia-Yue Li; Fen-Ling Liu; Ling Li; Jian-Li Jiang; Hong-Yong Cui; Zhi-Nan Chen
Journal:  J Exp Clin Cancer Res       Date:  2020-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.